Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent advances in the neuropsychopharmacology of serotonergic hallucinogens
Adam L. Halberstadt
Behavioural Brain Research (2014) Vol. 277, pp. 99-120
Open Access | Times Cited: 265

Showing 1-25 of 265 citing articles:

Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
Roland R. Griffiths, Matthew W. Johnson, Michael A. Carducci, et al.
Journal of Psychopharmacology (2016) Vol. 30, Iss. 12, pp. 1181-1197
Open Access | Times Cited: 1730
Psychedelics
David E. Nichols
Pharmacological Reviews (2016) Vol. 68, Iss. 2, pp. 264-355
Open Access | Times Cited: 1314
Neural correlates of the LSD experience revealed by multimodal neuroimaging
Robin Carhart‐Harris, Suresh Muthukumaraswamy, Leor Roseman, et al.
Proceedings of the National Academy of Sciences (2016) Vol. 113, Iss. 17, pp. 4853-4858
Open Access | Times Cited: 758
Serotonin and brain function: a tale of two receptors
RL Carhart-Harris, DJ Nutt
Journal of Psychopharmacology (2017) Vol. 31, Iss. 9, pp. 1091-1120
Open Access | Times Cited: 598
Psychedelics and Psychedelic-Assisted Psychotherapy
Collin Reiff, Elon E. Richman, Charles B. Nemeroff, et al.
American Journal of Psychiatry (2020) Vol. 177, Iss. 5, pp. 391-410
Closed Access | Times Cited: 462
Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder
Michael P. Bogenschutz, Stephen Ross, Snehal Bhatt, et al.
JAMA Psychiatry (2022) Vol. 79, Iss. 10, pp. 953-953
Open Access | Times Cited: 427
Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders
Franz X. Vollenweider, Katrin H. Preller
Nature reviews. Neuroscience (2020) Vol. 21, Iss. 11, pp. 611-624
Closed Access | Times Cited: 418
Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin
Michael Schartner, Robin Carhart‐Harris, Adam B. Barrett, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 367
The Fabric of Meaning and Subjective Effects in LSD-Induced States Depend on Serotonin 2A Receptor Activation
Katrin H. Preller, Marcus Herdener, Thomas Pokorny, et al.
Current Biology (2017) Vol. 27, Iss. 3, pp. 451-457
Open Access | Times Cited: 344
Psychedelics, Meditation, and Self-Consciousness
Raphaël Millière, Robin Carhart‐Harris, Leor Roseman, et al.
Frontiers in Psychology (2018) Vol. 9
Open Access | Times Cited: 314
Novel psychoactive substances of interest for psychiatry
Fabrizio Schifano, Laura Orsolini, Gabriele Duccio Papanti, et al.
World Psychiatry (2015) Vol. 14, Iss. 1, pp. 15-26
Open Access | Times Cited: 304
Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens
Anna Rickli, Olivier D. Moning, Marius C. Hoener, et al.
European Neuropsychopharmacology (2016) Vol. 26, Iss. 8, pp. 1327-1337
Open Access | Times Cited: 302
Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years
Rafael G. dos Santos, Flávia de Lima Osório, José Alexandre S. Crippa, et al.
Therapeutic Advances in Psychopharmacology (2016) Vol. 6, Iss. 3, pp. 193-213
Open Access | Times Cited: 274
The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms
Frederick S. Barrett, Matthew P. Bradstreet, Jeannie‐Marie Leoutsakos, et al.
Journal of Psychopharmacology (2016) Vol. 30, Iss. 12, pp. 1279-1295
Open Access | Times Cited: 269
Psychedelics not linked to mental health problems or suicidal behavior: A population study
Pål-Ørjan Johansen, Teri Suzanne Krebs
Journal of Psychopharmacology (2015) Vol. 29, Iss. 3, pp. 270-279
Closed Access | Times Cited: 256
Hallucinogens and Serotonin 5-HT2A Receptor-Mediated Signaling Pathways
Juan F. López‐Giménez, Javier González‐Maeso
Current topics in behavioral neurosciences (2017), pp. 45-73
Open Access | Times Cited: 227
Adverse effects of psychedelics: From anecdotes and misinformation to systematic science
Anne Katrin Schlag, Jacob S. Aday, Iram Salam, et al.
Journal of Psychopharmacology (2022) Vol. 36, Iss. 3, pp. 258-272
Open Access | Times Cited: 227
Classical psychedelics for the treatment of depression and anxiety: A systematic review
Silvia Muttoni, Maddalena Ardissino, Christopher John
Journal of Affective Disorders (2019) Vol. 258, pp. 11-24
Closed Access | Times Cited: 223
Neuropharmacology of N,N-dimethyltryptamine
Theresa M. Carbonaro, Michael B. Gatch
Brain Research Bulletin (2016) Vol. 126, pp. 74-88
Open Access | Times Cited: 206
Classic hallucinogens in the treatment of addictions
Michael P. Bogenschutz, Matthew W. Johnson
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2015) Vol. 64, pp. 250-258
Closed Access | Times Cited: 205
International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function
Nicholas M. Barnes, Gerard P. Ahern, Carine Bécamel, et al.
Pharmacological Reviews (2020) Vol. 73, Iss. 1, pp. 310-520
Open Access | Times Cited: 204
Whole-Brain Multimodal Neuroimaging Model Using Serotonin Receptor Maps Explains Non-linear Functional Effects of LSD
Gustavo Deco, Josephine Cruzat, Joana Cabral, et al.
Current Biology (2018) Vol. 28, Iss. 19, pp. 3065-3074.e6
Open Access | Times Cited: 202
Modern Clinical Research on LSD
Matthias E. Liechti
Neuropsychopharmacology (2017) Vol. 42, Iss. 11, pp. 2114-2127
Open Access | Times Cited: 198
Inclusion of people of color in psychedelic-assisted psychotherapy: a review of the literature
Timothy I. Michaels, Jennifer Purdon, Alexis Collins, et al.
BMC Psychiatry (2018) Vol. 18, Iss. 1
Open Access | Times Cited: 190
Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species
Adam L. Halberstadt, Muhammad Chatha, Adam K. Klein, et al.
Neuropharmacology (2020) Vol. 167, pp. 107933-107933
Open Access | Times Cited: 190
Page 1 - Next Page

Scroll to top